Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
In defense of generics: Not all are created equal.
Journal: Multiple sclerosis and related disorders
Published: August 16, 2024
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in the United States.
Journal: Neurology and therapy
Published: December 06, 2022
Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study.
Journal: Brain communications
Published: May 04, 2022
Digital Scientific Platform for Independent Content in Neurology: Rigorous Quality Guideline Development and Implementation.
Journal: Interactive journal of medical research
Published: December 14, 2021
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies.
Journal: Neurology and therapy
Published: April 01, 2021
Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate.
Journal: Current medical research and opinion
Published: April 25, 2020
Optic neuritis: Both eyes improve after corticotropin.
Journal: Journal of the neurological sciences
Published: August 15, 2019
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression.
Journal: Neurology and therapy
Published: January 10, 2019
Effectiveness of alternative dose fingolimod for multiple sclerosis.
Journal: Neurology. Clinical practice
Published: September 06, 2017
Last Updated: 09/26/2026